Search Within

Charles Rudin

Formats
  1. Journal Article (243)
  2. Meeting Abstract (223)
  3. Review (11)
  4. Editorial (10)
  5. Book Section (3)
  6. Guidelines (2)
  7. Research Letter (2)
  8. Correspondence (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (495)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (495)
  3. Department of Medicine (495)
  4. GSK Faculty (495)
  5. Solid Tumor Oncology Division (495)
  6. Thoracic Oncology (495)

More Groups

People
  1. Mark Kris (100)
  2. Natasha Rekhtman (96)
  3. Marc Ladanyi (93)
  4. Gregory Riely (76)
  5. Bob Li (72)
  6. Elisa De Stanchina (70)

More People

Years
  1. 2025 (18)
  2. 2024 (48)
  3. 2023 (43)
  4. 2022 (59)
  5. 2021 (52)
  6. 2020 (50)

More Years

Publications
  1. Journal of Clinical Oncology (83)
  2. Journal of Thoracic Oncology (79)
  3. Clinical Cancer Research (33)
  4. Cancer Research (31)
  5. Annals of Oncology (30)
  6. Cancer Discovery (15)

More Publications

Publishers
  1. Elsevier Inc. (105)
  2. American Society of Clinical Oncology (93)
  3. American Association for Cancer Research (86)
  4. Nature Publishing Group (45)
  5. Oxford University Press (40)
  6. Cell Press (28)

More Publishers

Results (495)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lung neuroendocrine neoplasms harboring ALK, RET and other receptor tyrosine kinase fusions: Spectrum of pathologic features from conventional neuroendocrine carcinomas to unusual carcinoid-type tumors with focal mucin or adenocarcinoma components
    Meeting Abstract

    Armstrong, S.; Chang, J.; Yang, S. R.; Samuel, T.; Hussain, S.; Velez, M.; Baine, M.; Travis, W.; Drilon, A.; Quintanal-Villalonga, A.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Characteristics and outcomes of patients with SMARCA4-deficient undifferentiated thoracic tumors
    Meeting Abstract

    Cooper, A.; Ricciuti, B.; Gagne, A.; Sholl, L.; Di Federico, A.; Awad, M.; Aldea, M.; Ghigna, M. R.; Grecea, M.; Chaft, J.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Ifinatamab deruxtecan (I-DXd) in extensive-stage small cell lung cancer (ES-SCLC): Interim analysis of IDeate-Lung01
    Meeting Abstract

    Rudin, C. M.; Ahn, M. J.; Johnson, M.; Hann, C. L.; Girard, N.; Nishio, M.; Cheng, Y.; Hayashi, H.; Jung Kim, Y.; Navarro, A.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Small cell lung cancer profiling: An updated synthesis of subtypes, vulnerabilities, and plasticity
    Review

    Redin, E.; Quintanal-Villalonga, Á; Rudin, C. M.
    Trends in Cancer (2024)

    Fulltext@MSK | Save
  • ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer
    Journal Article

    Taniguchi, H.; Chakraborty, S.; Takahashi, N.; Banerjee, A.; Caeser, R.; Zhan, Y. A.; Tischfield, S. E.; Chow, A.; Nguyen, E. M.; Villalonga, Á Q.; more...
    Science Advances (2024)

    Fulltext@MSK | Save
  • Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer
    Journal Article

    Elkrief, A.; Montesion, M.; Sivakumar, S.; Hale, C.; Bowman, A. S.; Begüm Bektaş, A.; Bradic, M.; Kang, W.; Chan, E.; Gogia, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Early circulating tumor DNA shedding kinetics for prediction of platinum sensitivity in patients with small cell lung cancer
    Journal Article

    Murciano-Goroff, Y. R.; Hui, A. B. Y.; Araujo Filho, J. A.; Hamilton, E. G.; Chabon, J. J.; Moding, E. J.; Bonilla, R. F.; Lebow, E. S.; Gomez, D.; Rimner, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • IDeate-Lung02: A phase 3, randomized, open-label study of ifinatamab deruxtecan (I-DXd) vs treatment of physician's choice (TPC) in relapsed small cell lung cancer (SCLC)
    Meeting Abstract

    Owonikoko, T. K.; Byers, L. A.; Cheng, Y.; Hayashi, H.; Paz-Ares, L. G.; Perol, M.; Turner, J.; Qian, M.; Garcia, C. R.; Godard, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save